CODEXIS INC (CDXS) Stock Price & Overview
NASDAQ:CDXS • US1920051067
Current stock price
The current stock price of CDXS is 2.61 USD. Today CDXS is down by -0.38%. In the past month the price increased by 63.75%. In the past year, price increased by 15.93%.
CDXS Key Statistics
- Market Cap
- 237.171M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.52
- Dividend Yield
- N/A
CDXS Stock Performance
CDXS Stock Chart
CDXS Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to CDXS. When comparing the yearly performance of all stocks, CDXS is one of the better performing stocks in the market, outperforming 85.62% of all stocks.
CDXS Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CDXS. Both the profitability and financial health of CDXS have multiple concerns.
CDXS Earnings
On March 11, 2026 CDXS reported an EPS of 0.11 and a revenue of 38.91M. The company beat EPS expectations (356.77% surprise) and beat revenue expectations (6.47% surprise).
CDXS Forecast & Estimates
13 analysts have analysed CDXS and the average price target is 6.71 USD. This implies a price increase of 157.28% is expected in the next year compared to the current price of 2.61.
For the next year, analysts expect an EPS growth of 15.26% and a revenue growth 10.49% for CDXS
CDXS Groups
Sector & Classification
CDXS Financial Highlights
Over the last trailing twelve months CDXS reported a non-GAAP Earnings per Share(EPS) of -0.52. The EPS increased by 42.22% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -29.75% | ||
| ROE | -87.03% | ||
| Debt/Equity | 0.79 |
CDXS Ownership
CDXS Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 21.55 | 195.48B | ||
| DHR | DANAHER CORP | 23.41 | 138.355B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 148.14 | 48.731B | ||
| A | AGILENT TECHNOLOGIES INC | 18.45 | 34.183B | ||
| WAT | WATERS CORP | 23.74 | 32.947B | ||
| IQV | IQVIA HOLDINGS INC | 14.03 | 29.673B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 28.77 | 26.824B | ||
| ILMN | ILLUMINA INC | 26.15 | 20.183B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 34.57 | 20.038B | ||
| MEDP | MEDPACE HOLDINGS INC | 30.14 | 15.092B | ||
| RVTY | REVVITY INC | 17.33 | 10.401B | ||
| TEM | TEMPUS AI INC-CL A | N/A | 10.186B | ||
| TECH | BIO-TECHNE CORP | 27.81 | 9.478B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About CDXS
Company Profile
Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. The company is headquartered in Redwood City, California and currently employs 146 full-time employees. The company went IPO on 2010-04-22. The company is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. The firm utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. The company is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) and other RNA-based therapeutics through an enzymatic route. The firm also uses the CodeEvolver platform technology to develop enzymes for the synthesis of RNAi therapeutics through its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.
Company Info
IPO: 2010-04-22
CODEXIS INC
200 Penobscot Dr
Redwood City CALIFORNIA 94063 US
CEO: John J. Nicols
Employees: 146
Phone: 16504218100
CODEXIS INC / CDXS FAQ
Can you describe the business of CODEXIS INC?
Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. The company is headquartered in Redwood City, California and currently employs 146 full-time employees. The company went IPO on 2010-04-22. The company is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. The firm utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. The company is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) and other RNA-based therapeutics through an enzymatic route. The firm also uses the CodeEvolver platform technology to develop enzymes for the synthesis of RNAi therapeutics through its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.
Can you provide the latest stock price for CODEXIS INC?
The current stock price of CDXS is 2.61 USD. The price decreased by -0.38% in the last trading session.
Does CDXS stock pay dividends?
CDXS does not pay a dividend.
What is the ChartMill rating of CODEXIS INC stock?
CDXS has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the market cap for CODEXIS INC?
CODEXIS INC (CDXS) has a market capitalization of 237.17M USD. This makes CDXS a Micro Cap stock.
Can you provide the upcoming earnings date for CODEXIS INC?
CODEXIS INC (CDXS) will report earnings on 2026-05-12.